CME-Directory

Description: The Merging and Redirecting Traffic: Exploiting the Biology of Renal Cell Carcinoma symposium is designed to update physicians on the latest information regarding the optimal treatment of patients with renal cell carcinoma using targeted agents and how to integrate this information into everyday practice. The symposium focuses on the current standard of care for patients with newly diagnosed disease, the optimal sequence of targeted agents in individualized therapy, the potential role of combining therapeutics in maximizing patient benefit, and emerging therapeutic agents and how they will be integrated into the treatment algorithm. This symposium will also address current options for the treatment of advanced disease following progression on previous targeted agents. This educational program is directed toward medical, surgical, and radiation oncologists with an interest in the treatment of kidney cancer. Fellows, oncology physician assistants, oncology nurses, and research nurses with an interest in the treatment of patients with kidney cancer are also invited to attend.

Location: ,

Credit Hours: